Amperometric polymer/enzyme composite (PEC) biosensors, incorporating a poly(o-phenylenediamine) ultra-thin permselective barrier, possess a variety of characteristics that make them suitable for monitoring brain energy and neurotransmitter dynamics in vivo. This review highlights PEC sensitivity and selectivity parameters, which allow development of the basic design in a systematic way in order to improve their performance and to diversify the analyte range of these novel probes of brain function. ª
Introduction
Understanding the mechanisms underlying the functioning of the human brain stands at the forefront of modern science. Behavior, feelings, thoughts and even consciousness itself may reflect the interplay of its electrical and chemical pathways. Clinical intervention in neurological disorders is usually achieved using chemical agents that act on neuromediator-related sites, suggesting that intercellular chemical signaling plays a major role in determining the properties of neural networks. However, measuring real-time chemical events in the living brain is a supreme technical challenge, even in animal models, and involves many biocompatibility issues. A growing number of analytical methodologies are being developed, including sampling [1, 2] , spectroscopic [3] and electrochemical [4] [5] [6] , to study neurochemical dynamics in the intact brain. One such set of techniques involves the in-situ detection of substances in brain extracellular fluid (ECF) using implanted biosensors.
Electrochemical biosensors exploit the specificity of a biological component, usually an enzyme immobilized on the electrode [7] [8] [9] [10] , to provide sensitivity to a target analyte. The chemical specificity can be very high, even to the level of stereoselectivity (e.g., the use of L L-glutamate oxidase (GluOx) in the design of amperometric biosensors to detect neurotransmitter L L-glutamate [11, 12] ). However, the remarkable specificity of enzyme-based amperometric biosensors can be seriously undermined by interference from electroactive species present in the target medium, compromising the selectivity of the device. This problem is particularly pronounced for biosensors implanted in biological tissues for realtime monitoring [9, 10, 13, 14] , because separation techniques cannot be exploited to eliminate the interference, as is the case for on-line microdialysis approaches to in-vivo monitoring [8, [15] [16] [17] . Despite this drawback, considerable efforts have been made over the past two decades to overcome issues of in-vivo biosensor sensitivity, selectivity and stability, mainly because of the significant benefits of biosensor monitoring: small probe size, minimizing tissue damage [18] [19] [20] ; and high time resolution, allowing real-time correlation with animal behavior [8, 10, 13, 21] .
Designs of biosensors for brain implantation
Biosensors are powerful analytical tools whose range of applications in medical diagnostics [22] , food-quality control [23] and environmental monitoring [24] is rapidly expanding. The design of an electrochemical biosensor is predicated first on the target analyte and the choice of appropriate biological element (e.g., L L-glutamate detection has been achieved using either glutamate receptor ion channels [22] , glutamate oxidase [25] or glutamate dehydrogenase [26] , and the respective electrochemical steps can be very different [22] ).
However, the vast majority of enzyme-based amperometric biosensors exploit the biocatalytic oxidation of analyte, using oxidase enzymes containing the prosthetic group, flavin adenine dinucleotide (FAD). Despite this common foundation, a wide range of oxidase-based devices have been designed to make use of different signal-transduction mechanisms and diverse selectivity strategies [7, 9, 10, 22, [26] [27] [28] [29] .
Another key factor shaping biosensor design is the nature of the intended application matrix [10, 24] (e.g., devices for monitoring analyte-concentration dynamics in vivo must be biocompatible over the time course of the implantation, both in terms of tissue effects on sensor functionality, and physiological reaction to the probe [20, 30, 31] ). As well as possessing the appropriate level of biocompatibility, implantable oxidase-based biosensors must also fulfill the following minimum criteria for reliable analyte monitoring: appropriate size and geometry [32, 33] ; good sensitivity to the enzyme substrate [34] ; effective rejection of electroactive interference [35, 36] ; and, low sensitivity to changes in pO 2 over the range of substrate and oxygen concentrations relevant to the intended application [11, 37] . Even different tissues present distinct challenges. For example, biosensors designed to monitor glucose in blood or subcutaneous fat in vivo need a significantly greater oxygen tolerance compared to devices for monitoring brain ECF [38] , because glucose levels are an order of magnitude higher in these peripheral tissues than in brain ECF [39] .
Within these restrictions, a number of biosensor designs have been developed and applied to monitor concentration dynamics of specific brain analytes in vivo. Among the first to be reported were those based on organic conducting salt tetrathiafulvalene tetracyanoquinodimethane (TTF-TCNQ) [40, 41] . Although initially thought to involve direct electron transfer between the FAD center and this novel conducting surface, there is now evidence that signal generation is mediated by TCNQ°from the electrode material [42, 43] . It is interesting to note that one of these seminal studies applied the concept of a ÔblankÕ sensor (one containing all the design elements of the biosensor, but omitting the enzyme) implanted beside the biosensor in order to minimize electroactive interference, using subtraction. This strategy was necessary because interference by ascorbic acid (AA, archetypal electroactive species that contaminates biosensor signals in vivo) can occur even at the low anodic potentials used for this class of biosensor [40, 44] . The use of blank sensors coupled with biosensors in difference mode is now seen as a vital component of reliable brain monitoring [33, 35, [45] [46] [47] [48] [49] [50] , although the use of a blank sensor does not mitigate the problem of oxygen dependence of oxidase-generated signals.
A more common design of biosensor used for analysis of brain systems (including brain slices in vitro and intact tissue in vivo) incorporates redox hydrogels (e.g., osmium poly(vinyl pyridine) redox polymer [51] [52] [53] ), and this biosensor design has also been implanted in peripheral tissues [54] . The Os-gel-HRP provides mediated electron transfer between the horseradish peroxidase, which reacts with the H 2 O 2 generated according to Reactions 1 and 2, and the electrode operating at mild cathodic applied potentials [35] . These devices may also include ascorbic acid oxidase and Nafion to reduce further interference by AA.
Neurochemical studies in vivo, using these probes, have been limited to acute implantation in anesthetized preparations, and it is unclear at present whether this class of biosensor is stable enough to allow long-term brain monitoring in freely-behaving animals. The presence of anesthetic is an important issue for in-vivo monitoring studies because different, and sometimes opposite, effects on neurochemical dynamics have been observed in the presence of anesthesia [10] . Thus, for example, it is unwise to test the glutamate/ascorbate heteroexchange hypothesis in chloral hydrate anesthetized rats, using this class of biosensor [50] , when it has been demonstrated explicitly that chloral hydrate blocks this exchange [55] .
A design, which has recently been implanted successfully for chronic recording in the brain of unanesthetized animals, exploits the anion-rejecting properties of Nafion as the main strategy for reducing electroactive interference at a ceramic-based biosensor [4, 56] , in addition to a blank or ÔsentinelÕ electrode to increase further the selectivity of the detection system [33, 49] . The biosensor signal is generated by direct oxidation of H 2 O 2 on the electrode surface (Reactions 1-3) at a relatively high applied anodic potential. Studies carried out over seven days showed that there was little loss of the sensitivity of the implanted differential device [33] , which indicates a promising future for this approach. However, an issue that needs to be addressed before widespread applications are undertaken is the oxygen dependence of these biosensors, which has yet to be reported. A variation on this design, which incorporates additional polymer layers deposited over a platinum substrate, has been applied for acute recording of brain glucose [57] , lactate [58] and glutamate [48] .
The use of poly-ortho-phenylenediamine (PPD) as a permselective membrane in the fabrication of implantable sensors and biosensors has been reported by a number of laboratories [59] [60] [61] [62] [63] [64] . Indeed, PPD has been used in the construction of biosensors for a range analytes in different target media [63, [65] [66] [67] [68] [69] [70] [71] . PPD can be deposited electrochemically from o-phenylenediamine (oPD) solutions at neutral pH to produce a thin, selfsealing, insulating polymer on the electrode surface [69] . Film-thickness estimations for PPD generated under these conditions are typically in the region of 10-30 nm [69, [72] [73] [74] . As well as possessing excellent interferencerejection characteristics, PPD also serves as a method of immobilizing enzymes and protects the electrode surface from fouling [39, 70] , making it ideal for biosensor applications in vivo [10] . The signal in this design is also generated by the direct oxidation of H 2 O 2 on the electrode surface (Reactions 1-3) at relatively high applied anodic potentials. A main advantage of PPD-based glucose biosensors is their stability, even during amperometric recording over days in freely behaving animals [39, 63, 75, 76] . In addition, the pO 2 dependence of both glucose- [38, 63] and glutamate- [11, 32, 77] detecting forms of these biosensors has been quantified in detail, and shown to be adequate for brain monitoring (see Section 6 below). Thus, although each design of biosensor for brain monitoring has a key advantage, such as the small cross-section of Os/gel/HRP-based carbonfiber electrodes [53, 78] and the self-referencing capability of the ceramic-based devices [49] , the overall long-term stability and oxygen tolerance of PPD-based biosensors make them an attractive choice for further development [11, 65, [79] [80] [81] [82] .
Here, we review the design of biosensors based on PPD polymer/enzyme composite (PEC) permselective layers for in-vivo neurochemical monitoring, with particular emphasis on the usefulness of biosensor sensitivity and selectivity parameters.
PEC-biosensor notation
To allow functionality in the electrochemically hostile environment of living brain tissue, implantable biosensors often contain a variety of components to enhance their sensitivity, selectivity and stability. These agents are laid down in an order that depends on their intended role, and so, in defining a systematic notation, this order must be clear. The nomenclature employed here uses a slash to indicate consecutive layering from left to right, Figure 1 . The effects of electrode geometry on the glucose response of GOx/PPD-based biosensors, illustrated by glucose calibrations performed using cylinder (C, ) and disk (D, o) based devices of the type where the GOx was adsorbed on the Pt before electropolymerization of PPD (see schematic on the right). Points are means ± SEM of current densities; curves were generated using non-linear regression and Equation (7a) (R 2 > 0.99). The enzyme loading density ( Equation 11) is much greater for the disk biosensors due to more efficient dip-evaporation enzyme deposition compared with cylinders [38] . However, the mean apparent K M value for glucose, K M (G), was not significantly different for these two designs: 15 ± 2 mM (n = 21); 15 ± 1 mM (n = 4); p > 0.94 [38] . Inset: Part of the linear region glucose response (Equation 10) for the Pt C / GOx/PPD configuration, showing the regression line with R 2 = 0.995 and using the same axis units as the main graph. Plots and schematic are adapted from [38] .
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Trends in Analytical Chemistry, Vol. 27, No. 1, 2008 while components deposited simultaneously are separated by a hyphen. For example: Pt/GOx/PPD represents glucose oxidase (GOx) deposited on Pt (normally by dip evaporation [77, 83] ) followed by electropolymerization of PPD (see Fig. 1 ); Pt/PPD/GOx indicates GOx deposited over electropolymerized PPD; and Pt/GOx-PPD signifies the co-deposition of enzyme and polymer by including GOx in the monomer solution. This notation is quite flexible and, where necessary, allows for such details as: the geometry of the electrode (e.g., disks (D) or cylinders (C) that can significantly affect biosensor performance [11, 77, 84 ] (see Fig. 1 
Enzyme-related biosensor parameters
A number of sophisticated mathematical models of the behavior of enzymes in membranes have been described [85, 86] . These complex analyses are often needed to understand and to optimize the behavior of thick and/or conducting layers [87] . However, a recent study has shown that substrate diffusion is not limiting for PPD layers incorporating enzymes [88] , due to their ultrathin nature (10-30 nm [69, 72, 74] ). The basic MichaelisMenten enzyme parameters used here therefore provide more readily accessible insights into factors affecting the responsiveness of biosensors fabricated from the insulating form of PPD, and avoid the use of more complex analyses, such as those involving the Thiele modulus [89] . For oxidase enzyme (E) with FAD as prosthetic group, the catalytic conversion of substrate (S) and co-substrate (O 2 ) to products (P) and H 2 O 2 can be written as Reactions (1)- (3):
The two-substrate form of the Michaelis-Menten equation for the overall rate of reaction, m, is given by Equation (4) [89, 90] :
If the concentration of the co-substrate is large and constant, Equation (4) reduces to:
Equation (5) represents the rate of product formation, which in this case reflects the rate of H 2 O 2 generation. The H 2 O 2 generated in the enzyme layer is the species detected at the electrode surface, but its bulk concentration is zero; it is the flux of H 2 O 2 from the immobilized enzyme to the conducting surface that determines the current. Converting the rate (Equation (5)) to current (Equation (6)) is achieved by multiplying both sides by AazF, where a is the fraction of the flux that is oxidized on the electrode of geometric area, A (some H 2 O 2 is lost to the bulk [76] ). Consistent with this analysis, many biosensor designs respond hyperbolically to the bulk concentration of enzyme substrate, and m 0 max (Equation (5)) is related to I max (Equation (6)) through the AazF term. The value of K M , the concentration of substrate that yields m max /2, does not change with this conversion. When comparing biosensors of different sizes, the response (I S ) can be normalized to current density (J S , Equation (7a)) by dividing by area, A. Nonlinear regression analysis of J S vs.
[S] provides the basic response parameters: J max , K M (S) and R 2 . Alternatively, if the concentration of S is fixed and O 2 levels are changed, then Equation (7b) can be used to analyze the oxygen dependence of the signal [32, 63] , where J 0 max is the maximum (plateau) response for a particular concentration of S, and K M (O 2 ) is the apparent Michaelis constant for oxygen.
The current density for the biosensor response to S, J S , is a measure of the overall rate of the enzyme reaction, and J max is the J S value at enzyme saturation. Different values of J max , determined under the same conditions, reflect differences in the activity of enzyme on the surface (k 2 [E]; see Reaction (8)) [38] , provided the sensitivity of the electrode to H 2 O 2 (Reaction (3)) does not vary much, as is the case for many of the PPD-modified Pt cylinders and disks used in brain monitoring [10, 63, 76] .
The Michaelis constant, K M , is defined in terms of the rate constants for the generalized reactions (Reaction (8)) describing the conversion of substrate to products, catalyzed by the enzyme (see Equation (9)). However, when Equation (7a) is used to approximate the twosubstrate case, K M is more complex and contains co-substrate terms. K M is then the apparent Michaelis constant and phenomenologically defines the concentration of substrate that gives half the J max response (see Fig. 1 ). Thus, changes in K M are sensitive to the binding constant, k 1 , and have been interpreted in terms of barriers to substrate/enzyme binding [70, 91] , as well as changes in oxygen demand [11, 38, 77, 92] . When comparing biosensor parameters based on different enzymes (e.g., GOx and GluOx (L L-glutamate oxidase)), it may be necessary to specify the enzyme substrate (e.g., K M (G) vs. [11, 77] .
The apparent Michaelis constant for S is also useful for defining the range of linear response to S (up to $1/2K M ), as well as the slope in the linear region (LRS), that is, LRS % J max /K M ; see Equation (10) .
Biosensors are usually designed to operate in real applications within their linear region response to analyte, which is generally considered to extend as far as K M /2. For biosensors incorporating GluOx, intended to detect low levels of Glu in biological samples, a critical property is high sensitivity in the linear region, whereas the range of linearity in not a problem. Since LRS % J max /K M (Equation (10)), increasing enzyme loading is a common strategy in the quest for increased LRS. However, the plot of LRS versus J max in Fig. 2 shows that the experimentally measured LRS does not increase with J max for Pt D /GluOx/PPD biosensors because there is a corresponding increase in K M (Glu) for this design due to electrostatic repulsion between the anionic Glu analyte and the high polyanionic enzyme density on these disk surfaces [84] . Neutralization of this repulsion by incorporating polycationic polyethyleneimine (PEI) into the PEC matrix restored this valuable correlation (Fig. 2) , allowing significant increases in LRS values [11] .
The turnover of O 2 in PEC membranes (Reaction (2)) depends on the rate at which substrate binds to the enzyme (Reaction (1)) (i.e. on substrate concentration). Glucose is an example of an analyte with relatively high concentrations in brain ECF, so it is a useful model system for quantifying PEC sensitivity to changes in ECF pO 2 . Experiments over a range of glucose concentrations, including 0.5, 2.5 and 10.0 mM glucose, were performed in vitro, where the pO 2 was controlled in a sealed environment, and the Pt/GluOx/PPD signal monitored as a function of dissolved oxygen concentration [38, 63] (see Fig. 3 ). The smaller the value of K M (O 2 ) in Equation (7b), the lower the oxygen dependence because higher oxygen affinity leads to oxygen saturation at lower pO 2 , thereby reducing biosensor dependency at higher pO 2 levels. As predicted, O 2 dependence became more acute at higher glucose concentrations. For 10-mM glucose, a level not much greater than the normoglycemic value in human blood [93] and less than that observed under hyperglycemic diabetic conditions [94] , the O 2 dependence was close to maximal (nearlinear biosensor response to pO 2 ) with a K m (O 2 ) = $150 lM [38] . The Pt/PPD/GOx sensor design would therefore not be suitable for monitoring blood glucose in vivo. Fig. 3 also shows the glucose-O 2 correlation plot for 0.5-mM glucose; the plot was hyperbolic, consistent with Equation (7b), with R 2 > 0.997, and values of K m (O 2 ) in the range 5-10 lM. The 0.5-mM glucose current therefore displayed a low insensitivity to changes in O 2 levels at average brain ECF levels of O 2 ($40 lM O 2 ). These in-vitro results suggest that Pt/PPD/GOx electrodes might be suitable for brain monitoring, where the estimated glucose level is much lower than that in blood. Indeed, ECF glucose has been determined to be an order of magnitude lower than blood levels by both quantitative microdialysis (350 ± 16 lM [39] ) and biosensor studies (300-400 lM [95] ) in the striatum of the awake rat. We discuss the experimental oxygen dependence of PEC-based biosensors in vivo in Section 6 below.
When the biosensor incorporates a component that significantly affects the sensitivity of the surface to H 2 O 2 (e.g., Nafion or lipid phosphatidylethanolamine (PEA)), then variations in J max across sensor populations may be due to changes in either enzyme activity or H 2 O 2 Figure 2 . Example of the effects of J max and K M on the linear region slope (LRS). J max was varied by controlling enzyme loading, and J max , K M and the LRS measured experimentally (see Fig. 1 An analogous, and possibly more useful, parameter, which also normalizes the biosensor response with respect to H 2 O 2 sensitivity, is biosensor efficiency (BE%) (see Equation (11a), where slope(S) is the LRS for enzyme substrate). In theory, the absolute maximum value of BE% should be 100% if the surface is saturated with enzyme, all the H 2 O 2 produced by the enzyme is electrooxidized on the surface, and the diffusion coefficients of S (D S ) and H 2 O 2 are equal. Since D S will always be less than that for H 2 O 2 ($1.0 · 10 À5 cm 2 /s) and some H 2 O 2 is lost to the bulk even in quiescent solution [76] , then (BE%) max < 100%. An empirical maximum appears to be close to 60% [84] , which is consistent with these factors.
Two additional parameters related to biosensor response to substrate, S, are useful. Response times can be recorded in constantly stirred solution, using a dataacquisition rate of >10 Hz [32] . A t 90% parameter has been defined as the time taken for the analyte response to reach 90% of its maximum value from the start (<10%) of the current upswing, and is similar to definitions used elsewhere [4, 50, 96] . The limit of detection (LOD) of S is usually determined using the widely applied criterion of three times the SD of the baseline. Response time and LOD are particularly crucial when designing biosensors to monitor fast transients in brain neurotransmitters whose ECF levels are invariably low (e.g., L L-glutamate, Glu). PEC-based devices (e.g., Pt/GluOx/PPD) show good behavior in these respects, with t 90% values of $3 s (just 1 s slower than to bulk H 2 O 2 ) and an LOD of <0.5 lM Glu [32, 83] .
Polymer-related biosensor parameters
The main analytical parameters of the surface polymer are related to Figure 3 . Increase in oxygen dependence at higher concentrations of substrate for Pt/GOx/PPD biosensors in vitro. Examples of averaged normalized glucose-oxygen correlation plots for three concentrations of glucose (filled circle, 0.5 mM, n = 3; open circle, 2.5 mM, n = 7; triangle, 10 mM, n = 6) studied over the relevant range of O 2 concentration (N 2 saturation to air saturation) showing the increased sensitivity of the biosensor signal to solution pO 2 as the concentration of glucose is increased [38, 63] . The non-linear regression plots shown were obtained using Equation (7b). Inset. The effect of systemic administration of the carbonic anhydrase inhibitor (Diamox, 50 mg/kg, i.p.) on the O 2 and glucose signals monitored simultaneously in vivo in rat brain striatum. Comparison of the O 2 current (black, recorded using DPA with a carbon paste electrode, CPE, in the left striatum) and glucose signal (grey, detected using amperometry at +700 mV with a Pt/GOx-PPD electrode in the right striatum) illustrates that O 2 availability does not impact significantly on glucose monitoring in brain ECF in vivo, where baseline glucose levels are in the region of 0.5 mM [39] . Plots are adapted from [63] . (1)- (3)); and, (ii) its ability to reject interference species, especially ascorbic acid (AA). The starting point for determining these properties is the sensitivity to H 2 O 2 and AA at the bare metal. First, the current-density responses of AA at bare microdisks and cylinders are the same, as are those of H 2 O 2 , indicating that subtle differences in diffusion profiles are not significant in this context [65, 97] . A direct comparison of the amperometric sensitivity of pure Pt and Pt-Ir has also been carried out [65, 98] . A small loss of H 2 O 2 sensitivity for the alloy compared with the pure metal was observed, presumably due to the involvement of Pt oxides in H 2 O 2 electro-oxidation. The greater sensitivity of both bare metal-electrode types for H 2 O 2 compared with AA is in line with diffusion-coefficient values for the two analytes and diffusion-limited kinetics at the operational applied potential (700 mV vs. SCE) [65] .
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Using a large population of wire electrodes, the hypothesis that ultra-thin (10-30 nm [69, 72, 74] ) electrosynthesized PPD does not decrease the sensitivity of Pt-Ir to H 2 O 2 has been tested [65] . Surprising, the large sample size revealed that PPD-modified Pt-Ir showed a small, but statistically significant, increase in the H 2 O 2 calibration slope (189 ± 10 lA/cm 2 /mM, n = 51) compared with the bare metal (171 ± 6 lA/cm 2 /mM, n = 51, p = 0.05 for a paired t-test). One possible explanation for the unexpected small increase in the efficiency of the electrochemical H 2 O 2 oxidation on the coated metal is that PPD inhibits the H 2 O 2 disproportionation reaction (Reaction (12)) at the electrode surface, the extent of which varies with electrode condition. However, it is clear that the basic Pt-Ir/PPD design displays near-optimal H 2 O 2 sensitivity, so that the only effective way to improve selectivity significantly is to increase interference blocking by the polymer layer. The more robust Pt-Ir working electrodes are therefore generally used for implantable biosensors in vivo, and normally designated as Pt for simplicity of notation. The permeability of the PEC layer to H 2 O 2 can therefore be defined as in Equation (13), and is normally about 100 ± 10% for the basic Pt/Ox/PPD designs [65, 97, 99] .
PðHPÞ% ¼ slopeðHPÞ at Pt=PEC Ã 100% slopeðHPÞ at Pt ð13Þ
An unusual property of PPD-based PEC layers is their ability to reject AA more efficiently at higher AA concentrations (Fig. 4) . Indeed, at extremely low levels of AA, the response of Pt/PPD electrodes is similar to bare Pt; however, even at 10-lM AA, AA sensitivity (I AA / [AA]) is considerably lower than that at bare metal [99] . AA, and/or its oxidation product, trapped in the polymer matrix therefore appears to cooperate efficiently with PPD in a form of ''self blocking'' [74, 99] , so that, by concentrations in the 100-lM region, the AA response is essentially flat (Fig. 4) . Because of this non-linear behavior of AA at Pt/PEC electrodes, the 1-mM value (plateau response, I lim ; see Fig. 4 ) is used in the corresponding definition of AA permeability, P(AA)% (Equation (14)).
PðAAÞ% ¼ I lim ðAAÞ at Pt=PEC Ã 100% slopeðAAÞ at Pt ð14Þ
The main focus in using P(HP)% is to maintain its value as close to 100% as possible (see above). The finding that values of P(HP)% greater than 100% have been observed indicates that this is not a true permeability, possibly due to complications (e.g., Reaction (12)). However, P(AA)% is very small ($0.2% [65, 74] ) and probably reflects the poor ability of AA to permeate the PEC layer. The problems with interpreting P(HP)% indicate that the permselectivity, S P %, defined by Equation (15) , is probably not the most useful parameter for quantifying PEC selectivity.
Instead, the equimolar selectivity, S%, defined by Equation (16) , is a good index of the relative sensitivities Figure 4 . The calibration profile obtained by plotting steady-state responses vs. AA concentration for Pt/PPD electrodes. Because of the non-linearity of the AA response at these electrodes, it is necessary to quantify the response in a number of ways. Firstly, the maximum current response, I max and the concentration at which I max occurs, C max . This parameter gives a good indication of the appropriate application of the sensors; for example, AA is present in tissues at concentrations ranging from 50 lM in blood to 500 lM in brain ECF. Thirdly, the current at 1 mM AA (generally the plateau region), I lim , which serves for comparisons of the absolute AA blocking ability of different polymers. Lastly, the current associated with the concentration change from 0.5 mM to 1 mM (i.e., equivalent to doubling brain ECF levels), DI, an even better indication of the interference blocking ability of the polymer in neurochemical analysis in vivo. Plot are adapted from [74] .
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Trends in Analytical Chemistry, Vol. 27, No. 1, 2008 of the PEC-coated metal to the two analytes. Because S% represents a percentage interference, the smaller the value, the more suitable the polymer is for biosensor applications, and values as low as $0.2% have been reported for PPD-based devices [65, 74] .
However, the polymer composite can also affect the behavior of the trapped enzyme [38, 77] . Thus, although S% is a good parameter for monitoring the effects of the polymer layer on relative H 2 O 2 and AA sensitivities, and a good (low) value of S% is a prerequisite for a successful biosensor design, it is not sufficient. Having established a good S% value, it is necessary to quantify the effects of the polymer composite on enabling the production of H 2 O 2 by the enzyme. The biosensor LRS for substrate is the best measure of the biosensorÕs analytical signal strength (see Equation (10)), incorporating both its ability to generate H 2 O 2 enzymatically and its electrochemical sensitivity to this molecule. Thus, we might define the equimolar substrate selectivity, S S %, by Equation (17), which will be intrinsically larger (worse) than S% due to factors discussed above.
Finally, the substrate concentration in the ECF needs to be taken into account by defining S S (ECF)% as Equation (18) , where I S (ECF) is the current for the estimated average baseline concentration of target analyte, S, obtained by scaling the LRS. S S (ECF)% is a measure of the contributions of AA and S to the baseline biosensor response recorded in the ECF.
S S ðECFÞ% ¼
I lim ðAAÞ at Pt=PEC Ã 100% I S ðECFÞ at Pt=PEC ð18Þ
A useful variation on S S (ECF)% is S S (ECF D )%, which is the substrate-selectivity parameter based on doubling baseline ECF levels of both S and AA (Equation (19) ). The significance of DI(AA) can be seen in Fig. 4 , and I S (ECF) has the same value as for Equation (18) . This latter parameter provides a measure of the percentage interference by AA in changes in the biosensor signal recorded in brain ECF, and therefore represents a key selectivity parameter for in vivo applications.
It is not so important that some of these later selectivity coefficients generate larger values than the more common standard S% parameter. More critical is the evolution of the value of the selectivity parameter of choice with systematic fine tuning of the biosensor design.
Brain monitoring with PEC-based biosensors in vivo
The high baseline levels of glucose in brain ECF ($0.5 mM [39] ), coupled with the excellent permselectivity of PPD-based biosensors, have made it possible to Figure 5 . The response of a Pt/GOx-PPD electrode implanted in the striatum of a freely-moving fasting rat over a 80-min period, 12 days after sensor implantation. Injection of insulin (15 U/kg, i.p. -see Inset) caused a decrease in the level of the signal which was reversed by the ingestion of food (see Inset) [75, 76] . Plots are adapted from [76] . monitor physiologically and pharmacologically related concentration dynamics of this energy metabolite in vivo [39, 61, 63, 75, 76, 100] . Many of these studies used devices of the type Pt/GOx-PPD because these can be fabricated in a one-step procedure by incorporating enzyme in the monomer solution, in contrast to the multiple dip-evaporation protocol for Pt/GOx/PPD sensors. In addition, the comparable sensitivity to glucose of these two designs has been demonstrated [83] .
As outlined in Section 2, a main advantage of PPDbased glucose biosensors is their stability, even during amperometric recording over several days in freely behaving animals [39, 63, 75, 76] . Fig. 5 shows the response of a Pt/GOx-PPD biosensor, which had been implanted in rat-brain striatum 12 days previously, to the systemic administration of insulin. The inset (Fig. 5) shows that this hormone produced a sustained depression in brain-ECF-glucose levels, which could be reversed by the ingestion of food (access to food had been restricted for the previous 12 h). The effects of insulin on brain-ECF glucose have been confirmed recently using a PPD-based biosensor incorporating a ruthenium layer [61] , although the baseline observed in vivo with these devices was not as stable as that recorded with Ru-free PEC design (Fig. 5) .
In addition to the PEC layer maintaining its sensitivity to brain glucose, the permselective membrane is also capable of rejecting AA interference after long periods implanted in the tissue. Fig. 6 shows that systemic administration of AA, at a dose that doubled brain-ECF AA levels (detected with an implanted carbon-paste electrode, CPE), had no significant effect on the Pt/GOx-PPD biosensor signal (inset, bottom). A similar combination of bilaterally implanted biosensor and CPE has been used to confirm the in-vitro findings (see Fig. 3 ) that, for physiologically relevant ECF concentrations of glucose and oxygen, oxygen demand does not limit biosensor functionality. Fig. 3 (inset) illustrates that systemic injection of a carbonic anhydrase inhibitor (Diamox), which significantly raised simultaneously monitored brain ECF pO 2 , had no detectable effect on the Pt/GOx-PPD signal [63] .
Taken together, the literature reports on Pt/GOx-PPD indicate that these biosensors possess sufficient glucose sensitivity, selectivity and stability to monitor this energy metabolite reliably in brain ECF over extended periods. However, the challenge remains to be how to boost PEC performance even further to allow the analogous Pt/ GluOx/PPD devices to monitor brain-ECF-Glu dynamics at levels two orders of magnitude lower than those of glucose. The incorporation of polycationic PEI into the PEC design has provided an important step in that direction by enhancing the Glu sensitivity significantly (see Fig. 2 ). Preliminary results in vivo with these PEI-modified biosensors indicate that long-term Glu monitoring may soon be possible with further fine turning of this design [45] .
